SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about transcript of conference call

11 Nov 2025 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed a copy of the transcript of the Company’s Q2FY26 earnings conference call, which the company shall be uploading on its website after sending this letter.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1627.50 -52.35 (-3.12%)
24-Apr-2026 10:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1627.50
Dr. Reddys Lab 1311.00
Cipla 1289.45
Zydus Lifesciences 927.75
Lupin 2299.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×